The signaling mechanism of ROS in tumor progression

Cancer and Metastasis Reviews

Volumn 25, Issue 4, 2006, Pages 695-705

  Wu, Wen Sheng ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Cell migration; MAPK; PKC; Reactive oxygen species; TGF ; Tumor progression

Indexed keywords

CATALASE; GLUTATHIONE TRANSFERASE; HYDROGEN PEROXIDE; INTEGRIN; LYCOPENE; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; P21 ACTIVATED KINASE; PROTEIN KINASE C; PROTEIN TYROSINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SMAD PROTEIN; TRANSCRIPTION FACTOR SNAIL;

ANGIOGENESIS; CELL ADHESION; CELL INVASION; CELL MIGRATION; CYTOSKELETON; EXTRACELLULAR MATRIX; GENE CONTROL; GENE EXPRESSION; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; REVIEW; TUMOR GROWTH;

ANIMALS; CELL MOVEMENT; DISEASE PROGRESSION; HUMANS; NEOPLASMS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 33846117134     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-006-9037-8     Document Type: Review

References (179)

1. Poli, G., Leonarduzzi, G., Biasi, F., & Chiarpotto, E. (2004). Oxidative stress and cell signalling. Current Medicinal Chemistry, 11, 1163-1182.
2. Aslan, M., & Ozben, T. (2003). Oxidants in receptor tyrosine kinase signal transduction pathways. Antioxidants & Redox Signalling, 5, 781-788.
3. Chiarugi, P. (2005). PTPs versus PTKs: The redox side of the coin. Free Radical Research, 39, 353-364.
4. Chiarugi, P. (2001). The redox regulation of LMW-PTP during cell proliferation or growth inhibition. IUBMB Life, 52, 55-59.
5. Boonstra, J., & Post, J. A. (2004). Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene, 337, 1-13.
6. Gourlay, C. W., & Ayscough, K. R. (2005). The actin cytoskeleton: A key regulator of apoptosis and ageing? Nature Reviews. Molecular Cell Biology, 6, 583-589.
7. Johann, A. M., von Knethen, A., Lindemann, D., & Brune, B. (2005). Recognition of apoptotic cells by macrophages activates the peroxisome proliferator-activated receptor-gamma and attenuates the oxidative burst. Cell Death and Differentiation, 13, 1533-1540.
8. Otani, H. (2004). Reactive oxygen species as mediators of signal transduction in ischemic preconditioning. Antioxidants & Redox Signalling, 6, 449-469.
9. Niedowicz, D. M., & Daleke, D. L. (2005). The role of oxidative stress in diabetic complications. Cell Biochemistry and Biophysics, 43, 289-330.
10. Okamoto, A., Iwamoto, Y., & Maru, Y. (2006). Oxidative stress-responsive transcription factor ATF3 potentially mediates diabetic angiopathy. Molecular and Cellular Biology, 26, 1087-1097.
11. Ambrosone, C. B. (2000). Oxidants and antioxidants in breast cancer. Antioxidants & Redox Signalling, 2, 903-917.
12. Klaunig, J. E., Xu, Y., Isenberg, J. S., Bachowski, S., Kolaja, K. L., Jiang, J., et al. (1998). The role of oxidative stress in chemical carcinogenesis. Environmental Health Perspectives, 106(Suppl. 1), 289-295.
13. Emerit, I. (1994). Reactive oxygen species, chromosome mutation, and cancer: Possible role of clastogenic factors in carcinogenesis. Free Radical Biology & Medicine, 16, 99-109.
14. Winter Toyokuni, S. (1999). Reactive oxygen species-induced molecular damage and its application in pathology. Pathology International, 49, 91-102, Review.
15. Storz, P. (2005). Reactive oxygen species in tumor progression. Frontiers in Bioscience,10, 1881-1896.
16. Radisky, D. C., Levy, D. D., Littlepage, L. E., Liu, H., Nelson, C. M., Fata, J. E., et al. (2005). Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature, 436, 123-127.
17. Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002). Dissemination and growth of cancer cells in metastatic sites. Nature Reviews. Cancer, 2, 563-572.
18. Bogenrieder, T., & Herlyn, M. (2003). Axis of evil: Molecular mechanisms of cancer metastasis. Oncogene, 22, 6524-6536.
19. Harlozinska, A. (2005). Progress in molecular mechanisms of tumor metastasis and angiogenesis. Anticancer Research, 25, 3327-3333.
20. Liotta, L. A., & Kohn, E. C. (2001). The microenvironment of the tumour-host interface. Nature,411, 375-379.
21. Kassis, J., Klominek, J., & Kohn, E. C. (2005). Tumor microenvironment: What can effusions teach us? Diagnostic Cytopathology, 33, 316-319.
22. Tanaka, T., Bai, Z., Srinoulprasert, Y., Yang, B. G., Hayasaka, H., & Miyasaka, M. (2005). Chemokines in tumor progression and metastasis. Cancer Science, 96, 317-322.
23. Brinckerhoff, C. E., & Matrisian, L. M. (2002). Matrix metalloproteinases: A tail of a frog that became a prince. Nature Reviews. Molecular Cell Biology, 3, 207-214.
24. Cully, M., You, H., Levine, A. J., & Mak, T. W. (2006). Beyond PTEN mutations: The PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nature Reviews. Cancer, 6, 184-192.
25. Nelson, K. K., & Melendez, J. A. (2004). Mitochondrial redox control of matrix metalloproteinases. Free Radical Biology & Medicine, 37, 768-784.
26. Matsuzawa, A., & Ichijo, H. (2005). Stress-responsive protein kinases in redox-regulated apoptosis signaling. Antioxidants & Redox Signalling, 7, 472-481.
27. Hordijk, P. L. (2006). Regulation of NADPH oxidases: The role of Rac proteins. Circulation Research, 98, 453-462.
28. Bokoch, G. M., & Diebold, B. A. (2002). Current molecular models for NADPH oxidase regulation by Rac GTPase. Blood, 100, 2692-2696.
29. Maulik, N., & Das, D. K. (2002). Redox signaling in vascular angiogenesis. Free Radical Biology & Medicine, 33, 1047-1460.
30. Eyries, M., Collins, T., & Khachigian, L. M. (2004). Modulation of growth factor gene expression in vascular cells by oxidative stress. Endothelium, 11, 133-139.
31. Lo, I. C., Shih, J. M., & Jiang, M. J. (2005). Reactive oxygen species and ERK 1/2 mediate monocyte chemotactic protein-1-stimulated smooth muscle cell migration. Journal of Biomedical Science, 12, 377-388.
32. Wang, Z., Castresana, M. R., & Newman, W. H. (2001). Reactive oxygen and NF-kappaB in VEGF-induced migration of human vascular smooth muscle cells. Biochemical and Biophysical Research Communications, 285, 669-674.
33. Tudor, K. S., Hess, K. L., & Cook-Mills, J. M. (2001). Cytokines modulate endothelial cell intracellular signal transduction required for VCAM-1-dependent lymphocyte transendothelial migration. Cytokine, 15, 196-211.
34. Datta, R., Yoshinaga, K., Kaneki, M., Pandey, P., & Kufe, D. (2000). Phorbol ester-induced generation of reactive oxygen species is protein kinase cbeta-dependent and required for SAPK activation. Journal of Biological Chemistry, 275, 41000-41003.
35. Mochizuki, T., Furuta, S., Mitsushita, J., Shang, W. H., Ito, M., Yokoo, Y., et al. (2006). Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells. Oncogene, 25(26), 3699-3707.
36. Landstrom, M., Heldin, N. E., Bu, S., Hermansson, A., Itoh, S., ten Dijke, P., et al. (2000). Smad7 mediates apoptosis induced by transforming growth factor beta in prostatic carcinoma cells. Current Biology, 10, 535-538.
37. Akhurst, R. J., & Derynck, R. (2001). TGF-beta signaling in cancer - a double-edged sword. Trends in Cell Biology, 11, S44-S51.
38. Yamamura, Y., Hua, X., Bergelson, S., & Lodish, H. F. (2000). Critical role of Smads and AP-1 complex in transforming growth factor-beta-dependent apoptosis. Journal of Biological Chemistry, 275, 36295-36302.
39. Chan, C. T., Li, S. H., & Verma, S. (2005). Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal disease. American Journal of Physiology. Renal Physiology, 289, F679-F684.
40. Sithanandam, G., Fornwald, L. W., Fields, J., & Anderson, L. M. (2005). Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549. Oncogene, 24, 1847-1859.
41. Rhyu, D. Y., Yang, Y., Ha, H., Lee, G. T., Song, J. S., Uh, S. T., et al. (2005). Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. Journal of the American Society of Nephrology, 16, 667-675.
42. Segarra, J., Balenci, L., Drenth, T., Maina, F., & Lamballe, F. (2006). Combined signaling through ERK, PI3K/AKT, and RAC1/p38 is required for met-triggered cortical neuron migration. Journal of Biological Chemistry, 281, 4771-4778.
43. Ren, Y., Cao, B., Law, S., Xie, Y., Lee, P. Y., Cheung, L., et al. (2005). Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: A prognostic marker of human esophageal squamous cell carcinomas. Clinical Cancer Research, 11, 6190-6197.
44. Daveau, M., Scotte, M., Francois, A., Coulouarn, C., Ros, G., Tallet, Y., et al. (2003). Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma. Molecular Carcinogenesis, 36, 130-141.
45. Ferraro, D., Corso, S., Fasano, E., Panieri, E., Santangelo, R., Borrello, S., et al. (2006). Pro-metastatic signaling by c-Met through RAC-1 and reactive oxygen species (ROS). Oncogene, 25(26), 3689-3698.
46. Dietrich, S., Uppalapati, R., Seiwert, T. Y., & Ma, P. C. (2005). Role of c-MET in upper aerodigestive malignancies - from biology to novel therapies. Journal of Environmental Pathology, Toxicology and Oncology, 24(3), 149-162.
47. Shimao, Y., Nabeshima, K., Inoue, T., & Koono, M. (1999). TPA-enhanced motility and invasion in a highly metastatic variant (L-10) of human rectal adenocarcinoma cell line RCM-1: Selective role of PKC-alpha and its inhibition by a combination of PDBu-induced PKC downregulation and antisense oligonucleotides treatment. Clinical & Experimental Metastasis, 17, 351-360.
48. Aprikian, A. G., Tremblay, L., Han, K., & Chevalier, S. (1997). Bombesin stimulates the motility of human prostate-carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin-associated proteins. International Journal of Cancer, 72, 498-504.
49. Schlingemann, J., Hess, J., Wrobel, G., Breitenbach, U., Gebhardt, C., Steinlein, P., et al. (2003). Profile of gene expression induced by the tumour promotor TPA in murine epithelial cells. International Journal of Cancer, 104, 699-708.
50. Woo, J. H., Lim, J. H., Kim, Y. H., Suh, S. I., Min do, S., Chang, J. S., et al. (2004). Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction. Oncogene, 23, 1845-1853.
51. Debidda, M., Sanna, B., Cossu, A., Posadino, A. M., Tadolini, B., Ventura, C., et al. (2003). NAMI-A inhibits the PMA-induced ODC gene expression in ECV304 cells: Involvement of PKC/Raf/Mek/ERK signalling pathway. International Journal of Oncology, 23, 477-482.
52. Woo, J. H., Park, J. W., Lee, S. H., Kim, Y. H., Lee, I. K., Gabrielson, E., et al. (2003). Dykellic acid inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting nuclear factor kappa B transcriptional activity. Cancer Research, 63, 3430-3434.
53. Wu, W. S., Tsai, R. K., Chang, C. H., Wang, S., Wu, J. R., & Chang, Y. X. (2006). Reactive oxygen species mediated sustained activation of protein kinase C α and ERK for migration of human hepatoma cell HepG2. Molecular Cancer Research, 4(10), 747-758.
54. Guo, W., & Giancotti, F. G. (2004). Integrin signalling during tumour progression. Nature Reviews. Molecular Cell Biology, 5, 816-826.
55. Kuphal, S., Bauer, R., & Bosserhoff, A. K. (2005). Integrin signaling in malignant melanoma. Cancer Metastasis Reviews, 24, 195-222.
56. Sheppard, D. (2005). Integrin-mediated activation of latent transforming growth factor beta. Cancer Metastasis Reviews, 24, 395-402.
57. Rucci, N., DiGiacinto, C., Orru, L., Millimaggi, D., Baron, R., & Teti, A. (2005). A novel protein kinase C alpha-dependent signal to ERK1/2 activated by alphaVbeta3 integrin in osteoclasts and in Chinese hamster ovary (CHO) cells. Journal of Cell Science, 118(Pt. 15), 3263-3275.
58. Hall, A. (2005). Rho GTPases and the control of cell behaviour. Biochemical Society Transactions, 33(Pt. 5), 891-895.
59. Grande-Garcia, A., Echarri, A., & Del Pozo, M. A. (2005). Integrin regulation of membrane domain trafficking and Rac targeting. Biochemical Society Transactions, 33, 609-613.
60. Juliano, R. L., Reddig, P., Alahari, S., Edin, M., Howe, A., & Aplin, A. (2004). Integrin regulation of cell signalling and motility. Biochemical Society Transactions, 32(Pt. 3), 443-446.
61. Burridge, K., & Wennerberg, K. (2004). Rho and Rac take center stage. Cell, 116, 167-179.
62. Zhou, H., & Kramer, R. H. (2005). Integrin engagement differentially modulates epithelial cell motility by RhoA/ROCK and PAK1. Journal of Biological Chemistry, 280, 10624-10635.
63. Hamelers, I. H., Olivo, C., Mertens, A. E., Pegtel, D. M., van der Kammen, R. A., Sonnenberg, A., et al. (2005). The Rac activator Tiam1 is required for (alpha)3(beta)1-mediated laminin-5 deposition, cell spreading, and cell migration. Journal of Cell Biology, 171, 871-881.
64. Nimnual, A. S., Taylor, L. J., & Bar-Sagi, D. (2003). Redox-dependent downregulation of Rho by Rac. Nature Cell Biology, 5, 236-241.
65. Mori, K., Shibanuma, M., & Nose, K. (2004). Invasive potential induced under long-term oxidative stress in mammary epithelial cells. Cancer Research, 64, 7464-7472.
66. Werner, E., & Werb, Z. (2002). Integrins engage mitochondrial function for signal transduction by a mechanism dependent on Rho GTPases. Journal of Cell Biology, 158, 357-368.
67. Radisky, D. C., Levy, D. D., Littlepage, L. E., Liu, H., Nelson, C. M., Fata, J. E., et al. (2005). Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature, 436, 123-127.
68. Yoon, S. O., Park, S. J., Yoon, S. Y., Yun, C. H., & Chung, A. S. (2002). Sustained production of H(2)O(2) activates pro-matrix metalloproteinase-2 through receptor tyrosine kinases/phosphatidylinositol 3-kinase/NF-kappa B pathway. Journal of Biological Chemistry, 277, 30271-30282.
69. Mori, K., Shibanuma, M., & Nose, K. (2004). Invasive potential induced under long-term oxidative stress in mammary epithelial cells. Cancer Research, 64, 7464-7472.
70. Choi, M. H., Lee, I. K., Kim, G. W., Kim, B. U., Han, Y. H., Yu, D. Y., et al. (2005). Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature, 435, 347-353.
71. Arakaki, N., Kajihara, T., Arakaki, R., Ohnishi, T., Kazi, J. A., Nakashima, H., et al. (1999). Involvement of oxidative stress in tumor cytotoxic activity of hepatocyte growth factor/scatter factor. Journal of Biological Chemistry, 274, 13541-1356.
72. Colavitti, R., Pani, G., Bedogni, B., Anzevino, R., Borrello, S., Waltenberger, J., et al. (2002). Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. Journal of Biological Chemistry, 277, 3101-3108.
73. Honore, S., Kovacic, H., Pichard, V., Briand, C., & Rognoni, J. B. (2003). Alpha2beta1-integrin signaling by itself controls G1/S transition in a human adenocarcinoma cell line (Caco-2): Implication of NADPH oxidase-dependent production of ROS. Experimental Cell Research, 285, 59-71.
74. Groth, S., Schulze, M., Kalthoff, H., Fandrich, F., & Ungefroren, H. (2005). Adhesion and Rac1-dependent regulation of biglycan gene expression by transforming growth factor-beta. Evidence for oxidative signaling through NADPH oxidase. Journal of Biological Chemistry, 280, 33190-33199.
75. Hu, T., Ramachandrarao, S. P., Siva, S., Valancius, C., Zhu, Y., Mahadev, K., et al. (2005). Reactive oxygen species production via NADPH oxidase mediates TGF-beta-induced cytoskeletal alterations in endothelial cells. American Journal of Physiology. Renal Physiology, 289, F816-F825.
76. Deem, T. L., & Cook-Mills, J. M. (2004). Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: Role of reactive oxygen species. Blood, 104, 2385-2393.
77. Yamazaki, D., Kurisu, S., & Takenawa, T. (2005). Regulation of cancer cell motility through actin reorganization. Cancer Science, 96, 379-386.
78. Bokoch, G. M., & Knaus, U. G. (2005). NADPH oxidases: Not just for leukocytes anymore! Trends in Biochemical Sciences, 28, 502-508.
79. Ushio-Fukai, M., & Alexander, R. W. (2004). Reactive oxygen species as mediators of angiogenesis signaling: Role of NAD(P) H oxidase. Molecular and Cellular Biochemistry, 264, 85-97.
80. Harfouche, R., Malak, N. A., Brandes, R. P., Karsan, A., Irani, K., & Hussain, S. N. (2005). Roles of reactive oxygen species in angiopoietin-1/tie-2 receptor signaling. FASEB Journal, 19, 1728-1730.
81. Arnold, R. S., Shi, J., Murad, E., Whalen, A. M., Sun, C. Q., Polavarapu, R., et al. (2001). Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1. Proceedings of the National Academy of Sciences of the United States of America, 98, 5550-5555.
82. Werner, E., & Werb, Z. (2002). Integrins engage mitochondrial function for signal transduction by a mechanism dependent on Rho GTPases. Journal of Cell Biology, 158, 357-368.
83. Nelson, K. K., & Melendez, J. A. (2004). Mitochondrial redox control of matrix metalloproteinases. Free Radical Biology & Medicine, 37, 768-784.
84. van Waveren, C., Sun, Y., Cheung, H. S., & Moraes, C. T. (2006). Oxidative phosphorylation dysfunction modulates expression of extracellular matrix - remodeling genes and invasion. Carcinogenesis, 27, 409-418.
85. Czarnecka, A. M., Golik, P., & Bartnik, E. (2006). Mitochondrial DNA mutations in human neoplasia. Journal of Applied Genetics, 47, 67-78.
86. Savaraj, N., Wei, Y., Unate, H., Liu, P. M., Wu, C. J., Wangpaichitr, M., et al. (2005). Redox regulation of matrix metalloproteinase gene family in small cell lung cancer cells. Free Radical Research, 39, 373-381.
87. Storz, G., & Polla, B. S. (1996). Transcriptional regulators of oxidative stress-inducible genes in prokaryotes and eukaryotes. EXS, 77, 239-254.
88. Rudolph, J. (2005). Redox regulation of the Cdc25 phosphatases. Antioxidants & Redox Signalling, 7, 761-767.
89. Poli, G., Leonarduzzi, G., Biasi, F., & Chiarpotto, E. (2004). Oxidative stress and cell signalling. Current Medicinal Chemistry, 11, 1163-1182.
90. Carter, C. A., & Kane, C. J. (2004). Therapeutic potential of natural compounds that regulate the activity of protein kinase C. Current Medicinal Chemistry, 11, 2883-2902.
91. Gomez, D. E., Skilton, G., Alonso, D. F., & Kazanietz, M. G. (1999). The role of protein kinase C and novel phorbol ester receptors in tumor cell invasion and metastasis (Review). Oncology Reports, 6, 1363-1370.
92. Petit, I., Goichberg, P., Spiegel, A., Peled, A., Brodie, C., Seger, R., et al. (2005). Atypical PKC-zeta regulates SDF-1-mediated migration and development of human CD34+ progenitor cells. Journal of Clinical Investigation, 115, 168-176.
93. Su, S., DiBattista, J. A., Sun, Y., Li, W. Q., & Zafarullah, M. (1998). Up-regulation of tissue inhibitor of metalloproteinases-3 gene expression by TGF-beta in articular chondrocytes is mediated by serine/threonine and tyrosine kinases. Journal of Cellular Biochemistry, 70, 517-527.
94. Disatnik, M. H., & Rando, T. A. (1999). Integrin-mediated muscle cell spreading. The role of protein kinase c in outside-in and inside-out signaling and evidence of integrin cross-talk. Journal of Biological Chemistry, 274, 32486-32492.
95. Parsons, M., Keppler, M. D., Kline, A., Messent, A., Humphries, M. J., Gilchrist, R., et al. (2002). Site-directed perturbation of protein kinase C-integrin interaction blocks carcinoma cell chemotaxis. Molecular and Cellular Biology, 22, 5897-5911.
96. Sliva, D. (2004). Signaling pathways responsible for cancer cell invasion as targets for cancer therapy. Current Cancer Drug Targets, 4, 327-336.
97. Shackelford, R. E., Kaufmann, W. K., & Paules, R. S. (2000). Oxidative stress and cell cycle checkpoint function. Free Radical Biology & Medicine, 28, 1387-1404.
98. Lin, D., & Takemoto, D. J. (2005). Oxidative activation of protein kinase Cgamma through the C1 domain. Effects on gap junctions. Journal of Biological Chemistry, 280, 13682-13693.
99. Inoguchi, T., Sonta, T., Tsubouchi, H., Etoh, T., Kakimoto, M., Sonoda, N., et al. (2003). Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: Role of vascular NAD(P)H oxidase. Journal of the American Society of Nephrology, 14, S227-232.
100. Lee, H. B., Yu, M. R., Yang, Y., Jiang, Z., & Ha, H. (2003). Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. Journal of the American Society of Nephrology, 14, S241-S245.
101. Velarde, V., de la Cerda, P. M., Duarte, C., Arancibia, F., Abbott, E., Gonzalez, A., et al. (2004). Role of reactive oxygen species in bradykinin-induced proliferation of vascular smooth muscle cells. Biological Research, 37, 419-430.
102. Greene, E. L., Lu, G., Zhang, D., & Egan, B. M. (2001). Signaling events mediating the additive effects of oleic acid and angiotensin II on vascular smooth muscle cell migration. Hypertension, 37, 308-312.
103. Srivastava, A. K. (2002). High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: A potential role in the pathogenesis of vascular dysfunction in diabetes (review). International Journal of Molecular Medicine, 9, 85-89.
104. Srivastava, A. K. (2002). High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: A potential role in the pathogenesis of vascular dysfunction in diabetes (review). International Journal of Molecular Medicine, 9(1), 85-89.
105. Chiarugi, P. (2005). PTPs versus PTKs: The redox side of the coin. Free Radical Research, 39, 353-364.
106. Lee, K., & Esselman, W. J. (2002). Inhibition of PTPs by H(2)O (2) regulates the activation of distinct MAPK pathways. Free Radical Biology & Medicine, 33, 1121-1132.
107. Meng, T. C., Fukada, T., & Tonks, N. K. (2002). Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Molecular Cell, 9, 387-399.
108. Goldstein, B. J., Mahadev, K., & Wu, X. (2005). Redox paradox: Insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets. Diabetes, 54, 311-321.
109. Chiarugi, P. (2003). Reactive oxygen species as mediators of cell adhesion. Italian Journal of Biochemistry, 2, 28-32.
110. Wu, R. F., Xu, Y. C., Ma, Z., Nwariaku, F. E., Sarosi, G. A. Jr, & Terada, L. S. (2005). Subcellular targeting of oxidants during endothelial cell migration. Journal of Cell Biology, 171, 893-904.
111. Schonwasser, D. C., Marais, R. M., Marshall, C. J., & Parker, P. J. (1998). Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Molecular and Cellular Biology, 18(2), 790-798.
112. Berra, E., Diaz-Meco, M. T., Lozano, J., Frutos, S., Municio, M. M., Sanchez, P., et al. (1995). Evidence for a role of MEK and MAPK during signal transduction by protein kinase C zeta. EMBO Journal, 14, 6157-6163.
113. Chernyavsky, A. I., Arredondo, J., Karlsson, E., Wessler, I., & Grando, S. A. (2005). The Ras/Raf-1/MEK1/ERK signaling pathway coupled to integrin expression mediates cholinergic regulation of keratinocyte directional migration. Journal of Biological Chemistry, 280, 39220-39228.
114. Shin, I., Kim, S., Song, H., Kim, H. R., & Moon, A. (2005). H-Ras-specific activation of Rac-MKK3/6-p38 pathway: Its critical role in invasion and migration of breast epithelial cells. Journal of Biological Chemistry, 280, 14675-14683.
115. Huang, C., Jacobson, K., & Schaller, M. D. (2004). MAP kinases and cell migration. Journal of Cell Science, 117(Pt. 20), 4619-4628.
116. Javelaud, D., & Mauviel, A. (2005). Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: Implications for carcinogenesis. Oncogene, 24, 5742-5750.
117. Nawshad, A., Lagamba, D., Polad, A., & Hay, E. D. (2005). Transforming growth factor-beta signaling during epithelial-mesenchymal transformation: Implications for embryogenesis and tumor metastasis. Cells, Tissues, Organs, 179, 11-23.
118. Howe, A. K., Aplin, A. E., & Juliano, R. L. (2002). Anchorage-dependent ERK signaling - mechanisms and consequences. Current Opinion in Genetics & Development, 12, 30-35.
119. Gupta, A., Rosenberger, S. F., & Bowden, G. T. (1999). Increased ROS levels contribute to elevated transcription factor and MAP kinase activities in malignantly progressed mouse keratinocyte cell lines. Carcinogenesis, 20, 2063-2073.
120. Lin, S. J., Shyue, S. K., Liu, P. L., Chen, Y. H., Ku, H. H., Chen, J. W., et al. (2004). Adenovirus-mediated overexpression of catalase attenuates oxLDL-induced apoptosis in human aortic endothelial cells via AP-1 and C-Jun N-terminal kinase/extracellular signal-regulated kinase mitogen-activated protein kinase pathways. Journal of Molecular and Cellular Cardiology, 36, 129-139.
121. Greene, E. L., Lu, G., Zhang, D., & Egan, B. M. (2001). Signaling events mediating the additive effects of oleic acid and angiotensin II on vascular smooth muscle cell migration. Hypertension, 37, 308-312.
122. Lo, I. C., Shih, J. M., & Jiang, M. J. (2005). Reactive oxygen species and ERK 1/2 mediate monocyte chemotactic protein-1-stimulated smooth muscle cell migration. Journal of Biomedical Science, 12, 377-388.
123. Rhyu, D. Y., Yang, Y., Ha, H., Lee, G. T., Song, J. S., Uh, S. T., et al. (2005). Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. Journal of the American Society of Nephrology, 16, 667-675.
124. Kruger, J. S., & Reddy, K. B. (2003). Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cells. Molecular Cancer Research, 1, 801-809.
125. Kermorgant, S., Zicha, D., & Parker, P. J. (2004). PKC controls HGF-dependent c-Met traffic, signalling and cell migration. EMBO Journal, 23, 3721-3734.
126. Wang, J., Frost, J. A., Cobb, M. H., & Ross, E. M. (1999). Reciprocal signaling between heterotrimeric G proteins and the p21-stimulated protein kinase. Journal of Biological Chemistry, 274, 31641-31647.
127. Juliano, R. L., Reddig, P., Alahari, S., Edin, M., Howe, A., & Aplin, A. (2004). Integrin regulation of cell signalling and motility. Biochemical Society Transactions, 32(Pt. 3), 443-446.
128. Fryer, B. H., & Field J. (2005). Rho, Rac, Pak and angiogenesis: Old roles and newly identified responsibilities in endothelial cells. Cancer Letters,229, 13-23.
129. Schmitz, U., Thommes, K., Beier, I., & Vetter, H. (2002). Lysophosphatidic acid stimulates p21-activated kinase in vascular smooth muscle cells. Biochemical and Biophysical Research Communications, 291, 687-691.
130. Harfouche, R., Malak, N. A., Brandes, R. P., Karsan, A., Irani, K., & Hussain, S. N. (2005). Roles of reactive oxygen species in angiopoietin-1/tie-2 receptor signaling. FASEB Journal, 19, 1728-1730.
131. Weber, D. S., Taniyama, Y., Rocic, P., Seshiah, P. N., Dechert, M. A., Gerthoffer, W. T., et al. (2004). Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species-dependent regulation of platelet-derived growth factor-induced smooth muscle cell migration. Circulation Research, 94, 1219-1226.
132. Liu, J. W., Chandra, D., Rudd, M. D., Butler, A. P., Pallotta, V., Brown, D., et al. (2005). Induction of prosurvival molecules by apoptotic stimuli: Involvement of FOXO3a and ROS. Oncogene, 24, 2020-2031.
133. Fujii, T., Onohara, N., Maruyama, Y., Tanabe, S., Kobayashi, H., Fukutomi, M., et al. (2005). Galpha12/13-mediated production of reactive oxygen species is critical for angiotensin receptor-induced NFAT activation in cardiac fibroblasts. Journal of Biological Chemistry, 280, 23041-23047.
134. Okamoto, A., Iwamoto, Y., & Maru, Y. (2006). Oxidative stress-responsive transcription factor ATF3 potentially mediates diabetic angiopathy. Molecular and Cellular Biology, 26, 108710-108797.
135. Hsu, T. C., Young, M. R., Cmarik, J., & Colburn, N. H. (2000). Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis. Free Radical Biology & Medicine, 28, 1338-1348.
136. Kim, M. H., Cho, H. S., Jung, M., Hong, M. H., Lee, S. K., Shin, B. A., et al. (2005). Extracellular signal-regulated kinase and AP-1 pathways are involved in reactive oxygen species-induced urokinase plasminogen activator receptor expression in human gastric cancer cells. International Journal of Oncology, 26, 1669-1674.
137. Seth, A., & Watson, D. K. (2005). ETS transcription factors and their emerging roles in human cancer. European Journal of Cancer, 41, 2462-2478.
138. Feldman, R. J., Sementchenko, V. I., Gayed, M., Fraig, M. M., & Watson, D. K. (2003). Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression. Cancer Research, 63, 4626-4631.
139. Hahne, J. C., Okuducu, A. F., Kaminski, A., Florin, A., Soncin, F., & Wernert, N. (2005). Ets-1 expression promotes epithelial cell transformation by inducing migration, invasion and anchorage-independent growth. Oncogene, 24, 5384-5388.
140. Huang, H. C., Liu, S. Y., Liang, Y., Liu, Y., Li, J. Z., & Wang, H. Y. (2005). [Transforming growth factor-beta1 stimulates matrix metalloproteinase-9 production through ERK activation pathway and upregulation of Ets-1 protein]. Zhonghua Yi Xue Za Zhi, 85, 328-331.
141. Chakraborti, S., Mandal, M., Das, S., Mandal, A., & Chakraborti, T. (2003). Regulation of matrix metalloproteinases: An overview. Molecular and Cellular Biochemistry, 253, 269-285.
142. White, L. A., Maute, C., & Brinckerhoff, C. E. (1997). ETS sites in the promoters of the matrix metalloproteinases collagenase (MMP-1) and stromelysin (MMP-3) are auxiliary elements that regulate basal and phorbol-induced transcription. Connective Tissue Research, 36, 321-335.
143. Wilson, L. A., Gemin, A., Espiritu, R., & Singh, G. (2005). Ets-1 is transcriptionally up-regulated by H2O2 via an antioxidant response element. FASEB Journal, 19, 2085-2087.
144. Roberts, A. B., Russo, A., Felici, A., & Flanders, K. C. (2003). Smad3: A key player in pathogenetic mechanisms dependent on TGF-beta. Annals of the New York Academy of Sciences, 995, 1-10.
145. Leivonen, S. K., Ala-Aho, R., Koli, K., Grenman, R., Peltonen, J., & Kahari, V. M. (2006). Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells. Oncogene, 25, 2588-2600.
146. Rhyu, D. Y., Yang, Y., Ha, H., Lee, G. T., Song, J. S., Uh, S. T., et al. (2005). Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. Journal of the American Society of Nephrology, 16, 667-675.
147. Huber, M. A., Kraut, N., & Beug, H. (2005). Molecular requirements for epithelial-mesenchymal transition during tumor progression. Current Opinion in Cell Biology,17, 548-558.
148. Zavadil, J., & Bottinger, E. P. (2005). TGF-beta and epithelial-to-mesenchymal transitions. Oncogene, 24, 5764-5774.
149. Barrallo-Gimeno, A., & Nieto, M. A. (2005). The Snail genes as inducers of cell movement and survival: Implications in development and cancer. Development, 132, 3151-3161.
150. Radisky, D. C., Levy, D. D., Littlepage, L. E., Liu, H., Nelson, C. M., Fata, J. E., et al. (2005). Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature, 436, 123-127.
151. Boonstra, J., & Post, J. A. (2004). Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene, 337, 1-13.
152. Lai, W. L., & Wong, N. S. (2005). ROS mediates 4HPR-induced posttranscriptional expression of the Gadd153 gene. Free Radical Biology & Medicine, 38, 1585-1593.
153. Nelson, K. K., & Melendez, J. A. (2004). Mitochondrial redox control of matrix metalloproteinases. Free Radical Biology & Medicine, 37, 768-784.
154. Westermarck, J., Li, S. P., Kallunki, T., Han, J., & Kahari, V. M. (2001). p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression. Molecular and Cellular Biology, 21, 2373-2383.
155. Savaraj, N., Wei, Y., Unate, H., Liu, P. M., Wu, C. J., Wangpaichitr, M., et al. (2005). Redox regulation of matrix metalloproteinase gene family in small cell lung cancer cells. Free Radical Research, 39, 373-381.
156. Lipscomb, E. A., & Mercurio, A. M. (2005). Mobilization and activation of a signaling competent alpha6beta4integrin underlies its contribution to carcinoma progression. Cancer Metastasis Reviews, 24, 413-423.
157. Kuphal, S., Bauer, R., & Bosserhoff, A. K. (2005). Integrin signaling in malignant melanoma. Cancer Metastasis Reviews, 24, 195-222.
158. Danen, E. H. (2005). Integrins: Regulators of tissue function and cancer progression. Current Pharmaceutical Design, 11, 881-891.
159. Playford, M. P., & Schaller, M. D. (2004). The interplay between Src and integrins in normal and tumor biology. Oncogene, 23, 7928-7946.
160. Zhu, H. J., Ross, F. P., Cao, X., & Teitelbaum, S. L. (1996). Phorbol myristate acetate transactivates the avian beta 3 integrin gene and induces alpha v beta 3 integrin expression. Journal of Cellular Biochemistry, 61, 420-429.
161. Lai, C. F., Feng, X., Nishimura, R., Teitelbaum, S. L., Avioli, L. V., Ross, F. P., et al. (2000). Transforming growth factor-beta upregulates the beta 5 integrin subunit expression via Sp1 and Smad signaling. Journal of Biological Chemistry, 275, 36400-36406.
162. Katabami, K., Mizuno, H., Sano, R., Saito, Y., Ogura, M., Itoh, S., et al. (2005). Transforming growth factor-beta1 upregulates transcription of alpha3 integrin gene in hepatocellular carcinoma cells via Ets-transcription factor-binding motif in the promoter region. Clinical & Experimental Metastasis, 22, 539-548.
163. Reynolds, A. B., & Roczniak-Ferguson, A. (2004). Emerging roles for p120-catenin in cell adhesion and cancer. Oncogene, 23, 7947-7956.
164. Rhyu, D. Y., Yang, Y., Ha, H., Lee, G. T., Song, J. S., Uh, S. T., et al. (2005). Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. Journal of the American Society of Nephrology, 16, 667-675.
165. Turcotte, S., Desrosiers, R. R., & Beliveau, R. (2003). HIF-1alpha mRNA and protein upregulation involves Rho GTPase expression during hypoxia in renal cell carcinoma. Journal of Cell Science, 116(Pt. 11), 2247-2260.
166. Wells, A. (2000). Tumor invasion: Role of growth factor-induced cell motility. Advances in Cancer Research, 78, 31-101.
167. Kataoka, H., Tanaka, H., Nagaike, K., Uchiyama, S., & Itoh, H. (2003). Role of cancer cell-stroma interaction in invasive growth of cancer cells. Human Cell, 16, 1-14.
168. Miura, Y., Kozuki, Y., & Yagasaki, K. (2003). Potentiation of invasive activity of hepatoma cells by reactive oxygen species is mediated by autocrine/paracrine loop of hepatocyte growth factor. Biochemical and Biophysical Research Communications, 305, 160-165.
169. Hu, T., Ramachandrarao, S. P., Siva, S., Valancius, C., Zhu, Y., Mahadev, K., et al. (2005). Reactive oxygen species production via NADPH oxidase mediates TGF-beta-induced cytoskeletal alterations in endothelial cells. American Journal of Physiology. Renal Physiology, 289, F816-F825.
170. Perez, L. M., Milkiewicz, P., Ahmed-Choudhury, J., Elias, E., Ochoa, J. E., Sanchez Pozzi, E. J., et al. (2006). Oxidative stress induces actin-cytoskeletal and tight-junctional alterations in hepatocytes by a Ca2+-dependent, PKC-mediated mechanism: Protective effect of PKA. Free Radical Biology & Medicine, 40, 2005-2017.
171. Fiaschi, T., Cozzi, G., Raugei, G., Formigli, L., Ramponi, G., & Chiarugi, P. (2006). Redox regulation of beta-actin during integrin-mediated cell adhesion. Journal of Biological Chemistry, 281(32), 22983-22991.
172. Pathak, S. K., Sharma, R. A., Steward, W. P., Mellon, J. K., Griffiths, T. R., & Gescher, A. J. (2005). Oxidative stress and cyclooxygenase activity in prostate carcinogenesis: Targets for chemopreventive strategies. European Journal of Cancer, 41, 61-70.
173. Sikka, S. C. (2003). Role of oxidative stress response elements and antioxidants in prostate cancer pathobiology and chemoprevention - a mechanistic approach. Current Medicinal Chemistry, 10, 2679-2692.
174. Nishikawa, M., Hyoudou, K., Kobayashi, Y., Umeyama, Y., Takakura, Y., & Hashida, M. (2005). Inhibition of metastatic tumor growth by targeted delivery. Journal of Controlled Release, 109, 101-107.
175. Gupta, A., Butts, B., Kwei, K. A., Dvorakova, K., Stratton, S. P., Briehl M. M., et al. (2001). Attenuation of catalase activity in the malignant phenotype plays a functional role in an in vitro model for tumor progression. Cancer Letters, 173, 115-125.
176. Nishino, H., Tokuda, H., Satomi, Y., Masuda, M., Osaka, Y., Yogosawa, S., et al. (2004). Cancer prevention by antioxidants. Biofactors, 22, 57-61.
177. Lin, J. K., Liang, Y. C., & Lin-Shiau, S. Y. (1999). Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade. Biochemical Pharmacology, 58, 911-915.
178. Taki, M., Verschueren, K., Yokoyama, K., Nagayama, M., & Kamata N. (2006). Involvement of Ets-1 transcription factor in inducing matrix metalloproteinase-2 expression by epithelial-mesenchymal transition in human squamous carcinoma cells. International Journal of Oncology, 28, 487-496.
179. Chakraborti, S., Mandal, M., Das, S., Mandal, A., & Chakraborti, T. (2003). Regulation of matrix metalloproteinases: An overview. Molecular and Cellular Biochemistry, 253(1-2), 269-285.